Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.

Meagher NS, Wang L, Rambau PF, Intermaggio MP, Huntsman DG, Wilkens LR, El-Bahrawy MA, Ness RB, Odunsi K, Steed H, Herpel E, Anglesio MS, Zhang B, Lambie N, Swerdlow AJ, Lubiński J, Vierkant RA, Goode EL, Menon U, Toloczko-Grabarek A, Oszurek O, Bilic S, Talhouk A, García-Closas M, Wang Q, Tan A, Farrell R, Kennedy CJ, Jimenez-Linan M, Sundfeldt K, Etter JL, Menkiszak J, Goodman MT, Klonowski P, Leung Y, Winham SJ, Moysich KB, Behrens S, Kluz T, Edwards RP, Gronwald J, Modugno F, Hernandez BY, Chow C, Kelemen LE, Keeney GL, Carney ME, Natanzon Y, Robertson G, Sharma R, Gayther SA, Alsop J, Luk H, Karpinskyj C, Campbell I, Sinn P, Gentry-Maharaj A, Coulson P, Chang-Claude J, Shah M, Widschwendter M, Tang K, Schoemaker MJ, Koziak JM, Cook LS, Brenton JD, Daley F, Kristjansdottir B, Mateoiu C, Larson MC, Harnett PR, Jung A, deFazio A, Gorringe KL, Pharoah PDP, Minoo P, Stewart C, Bathe OF, Gui X, Cohen P, Ramus SJ, Köbel M.

Mod Pathol. 2019 Jun 25. doi: 10.1038/s41379-019-0302-0. [Epub ahead of print]

PMID:
31239549
2.

Letter: impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease.

Ahmed T, Brown F, Ahmed R, Shah A, Whitehead S, Steed H, Brookes MJ.

Aliment Pharmacol Ther. 2019 Feb;49(4):476-477. doi: 10.1111/apt.15104. No abstract available.

PMID:
30689253
3.

Systematic review: the consequences of psychosocial effects of inflammatory bowel disease on patients' reproductive health.

Purewal S, Chapman S, Czuber-Dochan W, Selinger C, Steed H, Brookes MJ.

Aliment Pharmacol Ther. 2018 Dec;48(11-12):1202-1212. doi: 10.1111/apt.15019. Epub 2018 Nov 8.

4.

Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: System-wide implementation and audit leads to improved value and patient outcomes.

Bisch SP, Wells T, Gramlich L, Faris P, Wang X, Tran DT, Thanh NX, Glaze S, Chu P, Ghatage P, Nation J, Capstick V, Steed H, Sabourin J, Nelson G.

Gynecol Oncol. 2018 Oct;151(1):117-123. doi: 10.1016/j.ygyno.2018.08.007. Epub 2018 Aug 9.

PMID:
30100053
5.

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.

Rambau PF, Vierkant RA, Intermaggio MP, Kelemen LE, Goodman MT, Herpel E, Pharoah PD, Kommoss S, Jimenez-Linan M, Karlan BY, Gentry-Maharaj A, Menon U, Polo SH, Candido Dos Reis FJ, Doherty JA, Gayther SA, Sharma R, Larson MC, Harnett PR, Hatfield E, de Andrade JM, Nelson GS, Steed H, Schildkraut JM, Carney ME, Høgdall E, Whittemore AS, Widschwendter M, Kennedy CJ, Wang F, Wang Q, Wang C, Armasu SM, Daley F, Coulson P, Jones ME, Anglesio MS, Chow C, de Fazio A, García-Closas M, Brucker SY, Cybulski C, Harris HR, Hartkopf AD, Huzarski T, Jensen A, Lubiński J, Oszurek O, Benitez J, Mina F, Staebler A, Taran FA, Pasternak J, Talhouk A, Rossing MA, Hendley J; AOCS Group, Edwards RP, Fereday S, Modugno F, Ness RB, Sieh W, El-Bahrawy MA, Winham SJ, Lester J, Kjaer SK, Gronwald J, Sinn P, Fasching PA, Chang-Claude J, Moysich KB, Bowtell DD, Hernandez BY, Luk H, Behrens S, Shah M, Jung A, Ghatage P, Alsop J, Alsop K, García-Donas J, Thompson PJ, Swerdlow AJ, Karpinskyj C, Cazorla-Jiménez A, García MJ, Deen S, Wilkens LR, Palacios J, Berchuck A, Koziak JM, Brenton JD, Cook LS, Goode EL, Huntsman DG, Ramus SJ, Köbel M.

J Pathol Clin Res. 2018 Oct;4(4):250-261. doi: 10.1002/cjp2.109. Epub 2018 Sep 21.

6.

Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells.

Han X, Chen H, Zhou J, Steed H, Postovit LM, Fu Y.

Int J Mol Sci. 2018 Jul 26;19(8). pii: E2184. doi: 10.3390/ijms19082184.

7.

Prospective cohort study comparing quality of life and sexual health outcomes between women undergoing robotic, laparoscopic and open surgery for endometrial cancer.

Ferguson SE, Panzarella T, Lau S, Gien LT, Samouëlian V, Giede C, Steed H, Le T, Renkosinski B, Bernardini MQ.

Gynecol Oncol. 2018 Jun;149(3):476-483. doi: 10.1016/j.ygyno.2018.04.558. Epub 2018 Apr 19.

8.

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.

Block MS, Vierkant RA, Rambau PF, Winham SJ, Wagner P, Traficante N, Tołoczko A, Tiezzi DG, Taran FA, Sinn P, Sieh W, Sharma R, Rothstein JH, Ramón Y Cajal T, Paz-Ares L, Oszurek O, Orsulic S, Ness RB, Nelson G, Modugno F, Menkiszak J, McGuire V, McCauley BM, Mack M, Lubiński J, Longacre TA, Li Z, Lester J, Kennedy CJ, Kalli KR, Jung AY, Johnatty SE, Jimenez-Linan M, Jensen A, Intermaggio MP, Hung J, Herpel E, Hernandez BY, Hartkopf AD, Harnett PR, Ghatage P, García-Bueno JM, Gao B, Fereday S, Eilber U, Edwards RP, de Sousa CB, de Andrade JM, Chudecka-Głaz A, Chenevix-Trench G, Cazorla A, Brucker SY; Australian Ovarian Cancer Study Group, Alsop J, Whittemore AS, Steed H, Staebler A, Moysich KB, Menon U, Koziak JM, Kommoss S, Kjaer SK, Kelemen LE, Karlan BY, Huntsman DG, Høgdall E, Gronwald J, Goodman MT, Gilks B, García MJ, Fasching PA, de Fazio A, Deen S, Chang-Claude J, Candido Dos Reis FJ, Campbell IG, Brenton JD, Bowtell DD, Benítez J, Pharoah PDP, Köbel M, Ramus SJ, Goode EL.

Mayo Clin Proc. 2018 Mar;93(3):307-320. doi: 10.1016/j.mayocp.2017.10.023.

9.

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Ovarian Tumor Tissue Analysis (OTTA) Consortium, Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Tołoczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf A, Ryan A, Chudecka-Głaz A, Magliocco AM, Hartmann A, Jung AY, Gao B, Hernandez BY, Fridley BL, McCauley BM, Kennedy CJ, Wang C, Karpinskyj C, de Sousa CB, Tiezzi DG, Wachter DL, Herpel E, Taran FA, Modugno F, Nelson G, Lubiński J, Menkiszak J, Alsop J, Lester J, García-Donas J, Nation J, Hung J, Palacios J, Rothstein JH, Kelley JL, de Andrade JM, Robles-Díaz L, Intermaggio MP, Widschwendter M, Beckmann MW, Ruebner M, Jimenez-Linan M, Singh N, Oszurek O, Harnett PR, Rambau PF, Sinn P, Wagner P, Ghatage P, Sharma R, Edwards RP, Ness RB, Orsulic S, Brucker SY, Johnatty SE, Longacre TA, Ursula E, McGuire V, Sieh W, Natanzon Y, Li Z, Whittemore AS, Anna A, Staebler A, Karlan BY, Gilks B, Bowtell DD, Høgdall E, Candido dos Reis FJ, Steed H, Campbell IG, Gronwald J, Benítez J, Koziak JM, Chang-Claude J, Moysich KB, Kelemen LE, Cook LS, Goodman MT, García MJ, Fasching PA, Kommoss S, Deen S, Kjaer SK, Menon U, Brenton JD, Pharoah PDP, Chenevix-Trench G, Huntsman DG, Winham SJ, Köbel M, Ramus SJ.

JAMA Oncol. 2017 Dec 1;3(12):e173290. doi: 10.1001/jamaoncol.2017.3290.

10.

History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium.

Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender JB, Segal B, Odunsi K, Mayor P, Diergaarde B, Zsiros E, Kelemen LE, Köbel M, Steed H, deFazio A, Jordan SJ, Fasching PA, Beckmann MW, Risch HA, Rossing MA, Doherty JA, Chang-Claude J, Goodman MT, Dörk T, Edwards R, Modugno F, Ness RB, Matsuo K, Mizuno M, Karlan BY, Goode EL, Kjær SK, Høgdall E, Schildkraut JM, Terry KL, Cramer DW, Bandera EV, Paddock LE, Kiemeney LA, Massuger LFAG, Sutphen R, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, Kupryjanczyk J, Jensen A, Webb PM, Moysich KB; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group.

Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1470-1473. doi: 10.1158/1055-9965.EPI-17-0367.

11.

Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12.

Whitehead SJ, Ford C, Gama RM, Ali A, McKaig B, Waldron JL, Steed H, Brookes MJ.

J Clin Pathol. 2017 Dec;70(12):1049-1056. doi: 10.1136/jclinpath-2017-204340. Epub 2017 Jul 22.

PMID:
28735301
12.

History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.

Minlikeeva AN, Freudenheim JL, Cannioto RA, Szender JB, Eng KH, Modugno F, Ness RB, LaMonte MJ, Friel G, Segal BH, Odunsi K, Mayor P, Zsiros E, Schmalfeldt B, Klapdor R, Dӧrk T, Hillemanns P, Kelemen LE, Kӧbel M, Steed H, de Fazio A; Australian Ovarian Cancer Study Group, Jordan SJ, Nagle CM, Risch HA, Rossing MA, Doherty JA, Goodman MT, Edwards R, Matsuo K, Mizuno M, Karlan BY, Kjær SK, Høgdall E, Jensen A, Schildkraut JM, Terry KL, Cramer DW, Bandera EV, Paddock LE, Kiemeney LA, Massuger LF, Kupryjanczyk J, Berchuck A, Chang-Claude J, Diergaarde B, Webb PM, Moysich KB; Ovarian Cancer Association Consortium.

Cancer Causes Control. 2017 May;28(5):469-486. doi: 10.1007/s10552-017-0867-1. Epub 2017 Mar 14.

13.

Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications.

Rambau P, Kelemen LE, Steed H, Quan ML, Ghatage P, Köbel M.

Int J Mol Sci. 2017 Feb 27;18(3). pii: E515. doi: 10.3390/ijms18030515.

14.

Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles.

Kelemen LE, Rambau PF, Koziak JM, Steed H, Köbel M.

Cancer Causes Control. 2017 May;28(5):447-457. doi: 10.1007/s10552-017-0855-5. Epub 2017 Feb 13.

PMID:
28194593
15.

Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium.

Babic A, Cramer DW, Kelemen LE, Köbel M, Steed H, Webb PM, Johnatty SE, deFazio A, Lambrechts D, Goodman MT, Heitz F, Matsuo K, Hosono S, Karlan BY, Jensen A, Kjær SK, Goode EL, Pejovic T, Moffitt M, Høgdall E, Høgdall C, McNeish I, Terry KL.

Cancer Causes Control. 2017 May;28(5):459-468. doi: 10.1007/s10552-016-0841-3. Epub 2017 Jan 3.

16.

A Pilot Randomized, Controlled Trial of a Wall Climbing Intervention for Gynecologic Cancer Survivors.

Crawford JJ, Vallance JK, Holt NL, Bell GJ, Steed H, Courneya KS.

Oncol Nurs Forum. 2017 Jan 1;44(1):77-86.

PMID:
27991604
17.

Combined oral contraceptive use before the first birth and epithelial ovarian cancer risk.

Cook LS, Pestak CR, Leung AC, Steed H, Nation J, Swenerton K, Gallagher R, Magliocco A, Köbel M, Brooks-Wilson A, Le N.

Br J Cancer. 2017 Jan 17;116(2):265-269. doi: 10.1038/bjc.2016.400. Epub 2016 Dec 13.

18.

Tea, coffee, and caffeinated beverage consumption and risk of epithelial ovarian cancers.

Leung AC, Cook LS, Swenerton K, Gilks B, Gallagher RP, Magliocco A, Steed H, Köbel M, Nation J, Brooks-Wilson A, Le ND.

Cancer Epidemiol. 2016 Dec;45:119-125. doi: 10.1016/j.canep.2016.10.010. Epub 2016 Oct 27.

PMID:
27810483
19.

Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas.

Rambau PF, Duggan MA, Ghatage P, Warfa K, Steed H, Perrier R, Kelemen LE, Köbel M.

Histopathology. 2016 Aug;69(2):288-97. doi: 10.1111/his.12934. Epub 2016 Feb 26.

PMID:
26799366
20.

The hidden endoscopic burden of sleeve gastrectomy and its comparison with Roux-en-Y gastric bypass.

Arndtz K, Steed H, Hodson J, Manjunath S.

Ann Gastroenterol. 2016 Jan-Mar;29(1):44-9.

21.

Adult lifetime alcohol consumption and invasive epithelial ovarian cancer risk in a population-based case-control study.

Cook LS, Leung AC, Swenerton K, Gallagher RP, Magliocco A, Steed H, Koebel M, Nation J, Eshragh S, Brooks-Wilson A, Le ND.

Gynecol Oncol. 2016 Feb;140(2):277-84. doi: 10.1016/j.ygyno.2015.12.005. Epub 2015 Dec 12.

PMID:
26691218
22.

Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer.

Kelemen LE, Warren GW, Koziak JM, Köbel M, Steed H.

Gynecol Oncol. 2016 Jan;140(1):124-30. doi: 10.1016/j.ygyno.2015.11.008. Epub 2015 Nov 5.

PMID:
26549109
23.

Elevated β-catenin activity contributes to carboplatin resistance in A2780cp ovarian cancer cells.

Barghout SH, Zepeda N, Xu Z, Steed H, Lee CH, Fu Y.

Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):173-8. doi: 10.1016/j.bbrc.2015.10.138. Epub 2015 Oct 29.

PMID:
26522223
24.

RUNX3 contributes to carboplatin resistance in epithelial ovarian cancer cells.

Barghout SH, Zepeda N, Vincent K, Azad AK, Xu Z, Yang C, Steed H, Postovit LM, Fu Y.

Gynecol Oncol. 2015 Sep;138(3):647-55. doi: 10.1016/j.ygyno.2015.07.009. Epub 2015 Jul 15.

PMID:
26186909
25.

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.

Köbel M, Madore J, Ramus SJ, Clarke BA, Pharoah PD, Deen S, Bowtell DD, Odunsi K, Menon U, Morrison C, Lele S, Bshara W, Sucheston L, Beckmann MW, Hein A, Thiel FC, Hartmann A, Wachter DL, Anglesio MS, Høgdall E, Jensen A, Høgdall C, Kalli KR, Fridley BL, Keeney GL, Fogarty ZC, Vierkant RA, Liu S, Cho S, Nelson G, Ghatage P, Gentry-Maharaj A, Gayther SA, Benjamin E, Widschwendter M, Intermaggio MP, Rosen B, Bernardini MQ, Mackay H, Oza A, Shaw P, Jimenez-Linan M, Driver KE, Alsop J, Mack M, Koziak JM, Steed H, Ewanowich C, DeFazio A, Chenevix-Trench G, Fereday S, Gao B, Johnatty SE, George J, Galletta L; AOCS Study Group, Goode EL, Kjær SK, Huntsman DG, Fasching PA, Moysich KB, Brenton JD, Kelemen LE.

Br J Cancer. 2014 Dec 9;111(12):2297-307. doi: 10.1038/bjc.2014.567. Epub 2014 Oct 30.

26.

Tricuspid regurgitation on echocardiography may not be a predictor of patient survival after liver transplantation.

Leithead JA, Kandiah K, Steed H, Gunson BK, Steeds RP, Ferguson JW.

Am J Transplant. 2014 Sep;14(9):2192-3. doi: 10.1111/ajt.12821. Epub 2014 Jul 1. No abstract available.

27.

Biliary boulders.

Steed H, Lau K, Glass R, Durkin D, Deakin M, Green JRB.

Frontline Gastroenterol. 2014 Jul;5(3):161-166. doi: 10.1136/flgastro-2013-100391. Epub 2014 Jan 8.

28.

Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.

El-Sehemy A, Chang AC, Azad AK, Gupta N, Xu Z, Steed H, Karsan A, Fu Y.

Cell Signal. 2013 Dec;25(12):2780-7. doi: 10.1016/j.cellsig.2013.09.008. Epub 2013 Sep 13.

PMID:
24041655
29.

Effects of sample size on differential gene expression, rank order and prediction accuracy of a gene signature.

Stretch C, Khan S, Asgarian N, Eisner R, Vaisipour S, Damaraju S, Graham K, Bathe OF, Steed H, Greiner R, Baracos VE.

PLoS One. 2013 Jun 3;8(6):e65380. doi: 10.1371/journal.pone.0065380. Print 2013.

30.

Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?

Blackett KL, Siddhi SS, Cleary S, Steed H, Miller MH, Macfarlane S, Macfarlane GT, Dillon JF.

Aliment Pharmacol Ther. 2013 Jun;37(11):1084-92. doi: 10.1111/apt.12317. Epub 2013 Apr 22.

31.

Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells.

Gupta N, Xu Z, El-Sehemy A, Steed H, Fu Y.

Gynecol Oncol. 2013 Jul;130(1):200-6. doi: 10.1016/j.ygyno.2013.03.019. Epub 2013 Mar 29.

PMID:
23542683
32.

The hidden endoscopic burden of Roux-en-Y gastric bypass surgery.

Steed H, Golar H, Manjunath S.

Frontline Gastroenterol. 2013 Jan;4(1):69-72. doi: 10.1136/flgastro-2012-100268. Epub 2012 Dec 5.

33.

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.

Anglesio MS, Kommoss S, Tolcher MC, Clarke B, Galletta L, Porter H, Damaraju S, Fereday S, Winterhoff BJ, Kalloger SE, Senz J, Yang W, Steed H, Allo G, Ferguson S, Shaw P, Teoman A, Garcia JJ, Schoolmeester JK, Bakkum-Gamez J, Tinker AV, Bowtell DD, Huntsman DG, Gilks CB, McAlpine JN.

J Pathol. 2013 Jan;229(1):111-20. doi: 10.1002/path.4088.

PMID:
22899400
34.

Endoscopic retrograde cholangiopancreatography in nonagenarians: a decades-long experience in a single center.

Steed H.

J Am Geriatr Soc. 2011 Dec;59(12):2387-8. doi: 10.1111/j.1532-5415.2011.03704.x. No abstract available.

PMID:
22188091
35.

Unsedated percutaneous endoscopic gastrostomy insertion: a safe, effective, and well-tolerated method.

Steed H, Barrett D, Emm C, Lycett W, O'Toole S, Evans K, Hearing SD.

JPEN J Parenter Enteral Nutr. 2012 Mar;36(2):231-4. doi: 10.1177/0148607111410433. Epub 2011 Dec 16.

PMID:
22179522
36.

Bacterial translocation in cirrhosis is not caused by an abnormal small bowel gut microbiota.

Steed H, Macfarlane GT, Blackett KL, Macfarlane S, Miller MH, Bahrami B, Dillon JF.

FEMS Immunol Med Microbiol. 2011 Dec;63(3):346-54. doi: 10.1111/j.1574-695X.2011.00857.x. Epub 2011 Sep 8.

37.

A brief report on perceptions of alcohol and society among Scottish medical students.

Steed H, Groome M, Rice P, Simpson K, Day A, Ker J.

Alcohol Alcohol. 2012 Jan-Feb;47(1):75-8. doi: 10.1093/alcalc/agr139. Epub 2011 Nov 14.

PMID:
22085525
38.

Combined methotrexate-dactinomycin: an effective therapy for low-risk gestational trophoblastic neoplasia.

Eiriksson L, Wells T, Steed H, Schepansky A, Capstick V, Hoskins P, Pike J, Swenerton K.

Gynecol Oncol. 2012 Mar;124(3):553-7. doi: 10.1016/j.ygyno.2011.10.036. Epub 2011 Nov 9.

PMID:
22079360
39.

Anaemia is of prognostic significance in patients with oesophageal adenocarcinoma.

Tanswell I, Steed H, Butterworth J, Townson G.

J R Coll Physicians Edinb. 2011 Sep;41(3):206-10. doi: 10.4997/JRCPE.2011.304.

PMID:
21949914
40.

Aromatase inhibition: a potential target for the management of recurrent or metastatic endometrial cancer by letrozole: more questions than answers?

Steed HL, Chu QS.

Expert Opin Investig Drugs. 2011 May;20(5):681-90. doi: 10.1517/13543784.2011.566862. Epub 2011 Mar 18. Review.

PMID:
21413907
41.

Assessment of outcomes in surgically staged I/II endometrial adenocarcinoma patients treated with postoperative vaginal vault radiotherapy only.

Eiriksson L, Cuartero J, Steed H, Pearcey R, Capstick V, Schepansky A, Faught W, Dundas G.

Int J Gynecol Cancer. 2010 Nov;20(8):1356-62. doi: 10.1111/IGC.0b013e3181f21c4d.

PMID:
21051977
42.

Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers.

Slupsky CM, Steed H, Wells TH, Dabbs K, Schepansky A, Capstick V, Faught W, Sawyer MB.

Clin Cancer Res. 2010 Dec 1;16(23):5835-41. doi: 10.1158/1078-0432.CCR-10-1434. Epub 2010 Oct 18.

43.

TGFβ and EGF synergistically induce a more invasive phenotype of epithelial ovarian cancer cells.

Xu Z, Jiang Y, Steed H, Davidge S, Fu Y.

Biochem Biophys Res Commun. 2010 Oct 22;401(3):376-81. doi: 10.1016/j.bbrc.2010.09.059. Epub 2010 Sep 18.

PMID:
20854793
44.

Crohn's disease incidence in NHS Tayside.

Steed H, Walsh S, Reynolds N.

Scott Med J. 2010 Aug;55(3):22-5.

PMID:
20795513
45.

Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease.

Steed H, Macfarlane GT, Blackett KL, Bahrami B, Reynolds N, Walsh SV, Cummings JH, Macfarlane S.

Aliment Pharmacol Ther. 2010 Oct;32(7):872-83. doi: 10.1111/j.1365-2036.2010.04417.x.

46.

Evaluation of a new core curriculum on alcohol use disorders for undergraduate medical students.

Steed H, Groome M, Rice P, Simpson K, Day A, Ker J.

Alcohol Alcohol. 2010 Jul-Aug;45(4):395-7. doi: 10.1093/alcalc/agq024. Epub 2010 May 25.

PMID:
20501550
47.

A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland.

Steed H, Walsh S, Reynolds N.

Obes Facts. 2009;2(6):370-2. doi: 10.1159/000262276. Epub 2009 Dec 17.

48.

A population-based study of the determinants of physical activity in ovarian cancer survivors.

Stevinson C, Tonkin K, Capstick V, Schepansky A, Ladha AB, Valance JK, Faught W, Steed H, Courneya KS.

J Phys Act Health. 2009 May;6(3):339-46.

PMID:
19564663
49.

The gut microbiota in inflammatory bowel disease.

Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S.

Curr Pharm Des. 2009;15(13):1528-36. Review.

PMID:
19442170
50.

Physical activity in ovarian cancer survivors: associations with fatigue, sleep, and psychosocial functioning.

Stevinson C, Steed H, Faught W, Tonkin K, Vallance JK, Ladha AB, Schepansky A, Capstick V, Courneya KS.

Int J Gynecol Cancer. 2009 Jan;19(1):73-8. doi: 10.1111/IGC.0b013e31819902ec.

PMID:
19258945

Supplemental Content

Support Center